Abstract: This paper challenges the conventional wisdom regarding the standard used by the FDA to approve new drugs. In particular, this paper shows how the FDA definition of effectiveness as effective beyond a placebo negatively impacts public health by denying consumers the benefit of a proven placebo treatment even when it is the only, or the safest, treatment available.
Public Health and the Placebo
The Legacy of the 1906 Pure Food and Drug Act
Russell S. Sobel is a Professor of Economics & Entrepreneurship at The Citadel.
Comments
Before posting, please read our Comment Policy.